How to Buy Neuronetics Stock
Neuronetics Inc
Neuronetics, Inc. , a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
Neuronetics stock last closed at $2.56, down 0.39% from the previous day, and has decreased 12.33% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.08 percentage points. Neuronetics stock is currently +27.36% from its 52-week low of $2.01, and -63.18% from its 52-week high of $6.95.
There are currently 28.5M STIM shares outstanding. The market value of STIM is $72.96M. In the past 24 hours, 91,929 STIM shares were traded.
How to Buy Neuronetics Stock
Wondering how to invest in Neuronetics stock? Here's how.
- Choose where to buy Neuronetics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Neuronetics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Choose your method of payment and add your info.
- Research Neuronetics stock: The Neuronetics ticker symbol is STIM. Is Neuronetics stock a good investment? Should you buy shares of STIM? How do STIM's underlying business fundamentals look? Do top analysts think Neuronetics is a good buy? Why has STIM's stock price moved recently? (Hint: Our stock analysis website can help you understand if STIM is a good stock to buy).
- Make your STIM trade: Decide if you will purchase STIM shares at the current market price or use a limit order to buy STIM shares at a specific price.
- Keep an eye on your STIM investment: Create a watchlist to important updates regarding your investment in Neuronetics shares.
Step 1: Choose where to buy Neuronetics stock
You will need a brokerage account in order to access the NASDAQ market and buy STIM stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Energy, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to invest in STIM today.
How to Open a New Brokerage Account on eToro
- Click here to get started.
- Provide your personal data to open a new trading account.
- Submit your details by hitting the "Create Account" button.
Step 3: Deposit funds into your investment account
Now that you have created your account on the best stock buying app, you need to deposit funds:
Check out the tutorial below for more details depositing money into your brokerage account.
Step 4: Research Neuronetics stock
After you have chosen the best place to buy Neuronetics stock, it's critical to analyze their stock prior to investing, so you actually comprehend the risk and upside.
Neuronetics shares quick numbers
Neuronetics Due Diligence Checks
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on STIM's stock page.
Is STIM stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge STIM's true value.
Using relative valuations measures:
- STIM may be undervalued based on its P/B ratio of 1.51x, relative to Diagnostics & Research industry P/B ratio of 4.01x
You can access more valuation research on STIM's stock here.
STIM Financial Health Summary
Signs that STIM is financially healthy:
- STIM has $58.20M in cash and short term investments. This is sufficient to cover its annual cash burn of $36.20M.
- STIM has cash burn of 36199000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the STIM balance sheet.
- There are more short-term assets than short-term liabilities on the STIM balance sheet.
Signs that STIM is not financially healthy:
- STIM has a relatively high debt to equity ratio of 1.14.
- STIM profit margin has gone up by 0.04 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy STIM stock, according to analysts?
Out of 2 Equities analysts who research STIM, the consensus analyst rating on STIM is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent STIM Analyst Ratings
David Turkaly, a bottom 8% analyst from JMP Securities reiterates STIM with a buy rating and maintains their STIM price target from $12.00 to $12.00, on May 10, 2023.
William Plovanic, a bottom 18% analyst from Canaccord Genuity maintains STIM with a strong buy rating and lowers their STIM price target from $9.00 to $7.00, on Mar 8, 2023.
You can dig deeper into what analysts are saying on the Neuronetics stock forecast page.
STIM Technicals
Is STIM Making Money?
Last year, STIM revenue was $66.57M. In the last 5 year, STIM's revenue has gone up by 9.1% per year. This was slower than the Diagnostics & Research industry average of 15.17%.
You can research STIM's earnings and revenue performance here.
What are STIM executives and large shareholders up to?
In the past year, executives and large shareholders at STIM have sold more shares than they have bought.
John K. Bakewell, Director of STIM, was the latest STIM insider to sell. They sold $38,880.00 worth of STIM shares on May 24, 2023.
Dig into more about who owns STIM stock here.
Does STIM stock generate passive income?
No, Neuronetics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your STIM trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount limit, use a limit order.
Click the Open button and your broker will execute the order.
If you require additional help investing in stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your STIM investment
Now that you own some STIM shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to get notified of the latest news about your STIM stock.
STIM Feed
How to Buy Stock in Neuronetics
To summarize, here are the 6 steps to buy Neuronetics stock:
- Choose where to buy Neuronetics stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Research Neuronetics stock
- Make your STIM trade
- Keep an eye on your STIM investment
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Neuronetics, add STIM to your watchlist by clicking the button below.
More Articles You May Like
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.